Business, energy, technology, markets and global industry news from Business News Today

Profound Medical Corp.

PharmaDeviceNews Profound Medical Corp.
Representative image: Telix Pharmaceuticals’ PSMA-PET imaging collaborations with EDAP TMS and Profound Medical highlight how advanced prostate cancer scans could support minimally invasive treatment planning, focal ablation decisions and post-treatment monitoring in next-generation urology workflows.
Medical Devices & Diagnostics

Why Telix is taking PSMA-PET deeper into minimally invasive prostate cancer treatment

Prostate ablation is getting more precise. Telix wants PSMA-PET to become the imaging layer that helps clinicians decide where to treat.

Read More